Biocon Limited (NSE: BIOCON)
India
· Delayed Price · Currency is INR
324.60
-2.45 (-0.75%)
Nov 21, 2024, 11:19 AM IST
Biocon Revenue
Biocon had revenue of 35.90B INR in the quarter ending September 30, 2024, with 3.70% growth. This brings the company's revenue in the last twelve months to 148.94B, up 9.52% year-over-year. In the fiscal year ending March 31, 2024, Biocon had annual revenue of 147.56B with 32.05% growth.
Revenue (ttm)
148.94B
Revenue Growth
+9.52%
P/S Ratio
2.60
Revenue / Employee
9.13M
Employees
16,315
Market Cap
386.69B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
Mar 31, 2021 | 71.43B | 8.43B | 13.37% |
Mar 31, 2020 | 63.01B | 7.86B | 14.26% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionBiocon News
- 10 days ago - Biocon shares surge over 3% after Bengaluru facilities get VAI Tag from USFDA - Business Upturn
- 10 days ago - Stocks to watch today: Divi’s Laboratories, JSW Steel, LIC, Biocon in focus; Asian Paints, Tata Motors, Aurobindo Pharma, Ola Electric under pressure - Business Upturn
- 14 days ago - Access to healthcare will remain a priority for the US, says Biocon CEO - CNBC
- 17 days ago - Pharma Sector Stocks: Granules down 1.68%, Akums slips 1.29%, Zydus Life up 0.13%, Aurobindo Pharma gains 0.99% in early trade - Business Upturn
- 21 days ago - Stocks to watch today: L&T, Voltas, Dabur, Aditya Birla Capital, Tata Power, and Biocon post Q2 results – Brokerage reports inside - Business Upturn
- 22 days ago - Biocon Q2 FY25 Results: Company posts net loss of Rs 16 crore, Revenue flat at Rs 3,623 crore - Business Upturn
- 22 days ago - Stocks to watch today as key Q2 FY24-25 results roll in: L&T, Tata Power, Dabur, PGHH, Biocon, Aditya Birla Capital and more - Business Upturn
- 4 weeks ago - HSBC on Biocon: Reduce call, sees 7.8% downside from current share price - Business Upturn